These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3804888)

  • 1. Rifampicin resistance in a strain of Brucella melitensis after treatment with doxycycline and rifampicin.
    De Rautlin de la Roy YM; Grignon B; Grollier G; Coindreau MF; Becq-Giraudon B
    J Antimicrob Chemother; 1986 Nov; 18(5):648-9. PubMed ID: 3804888
    [No Abstract]   [Full Text] [Related]  

  • 2. Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis.
    Ariza J; Bosch J; Gudiol F; Liñares J; Viladrich PF; Martín R
    Antimicrob Agents Chemother; 1986 Dec; 30(6):958-60. PubMed ID: 3813520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antibacterial activity of tigecycline in comparison with doxycycline, ciprofloxacin and rifampicin against Brucella spp.
    Turan H; Arslan H; Azap OK; Serefhanoğlu K; Uncu H
    Int J Antimicrob Agents; 2007 Aug; 30(2):186-7. PubMed ID: 17462865
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of combinations of doxycycline and rifampicin in the therapy of experimental mouse brucellosis.
    Shasha B; Lang R; Rubinstein E
    J Antimicrob Chemother; 1994 Mar; 33(3):545-51. PubMed ID: 8040118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility of
    Shevtsov A; Syzdykov M; Kuznetsov A; Shustov A; Shevtsova E; Berdimuratova K; Mukanov K; Ramankulov Y
    Antimicrob Resist Infect Control; 2017; 6():130. PubMed ID: 29299304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of long-term ethanol feeding on efficacy of doxycycline plus rifampicin in the treatment of experimental brucellosis caused by Brucella melitensis in rats.
    Yumuk Z; Dundar V
    J Chemother; 2005 Oct; 17(5):509-13. PubMed ID: 16323439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas.
    Solera J; Rodríguez-Zapata M; Geijo P; Largo J; Paulino J; Sáez L; Martínez-Alfaro E; Sánchez L; Sepulveda MA; Ruiz-Ribó MD
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2061-7. PubMed ID: 8540716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of experimental murine brucellosis with streptomycin alone and in combination with ciprofloxacin, doxycycline, and rifampin.
    Lang R; Shasha B; Rubinstein E
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2333-6. PubMed ID: 8285615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of brucellosis using rifampicine (author's transl)].
    Bertrand A; Roux J; Janbon F; Jourdan J; Jonquet O
    Nouv Presse Med; 1979 Nov; 8(44):3635-9. PubMed ID: 534216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on antimicrobial susceptibility of Brucella in a city].
    Zuo SW; Ni ZL; Yao YB; Yang RS; Wang SK; Zhou YH
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2017 Dec; 35(12):939-941. PubMed ID: 29495161
    [No Abstract]   [Full Text] [Related]  

  • 11. Failure of prolonged treatment with ciprofloxacin in acute infections due to Brucella melitensis.
    Lang R; Raz R; Sacks T; Shapiro M
    J Antimicrob Chemother; 1990 Dec; 26(6):841-6. PubMed ID: 2081722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis.
    Ariza J; Gudiol F; Pallarés R; Rufí G; Fernández-Viladrich P
    Antimicrob Agents Chemother; 1985 Oct; 28(4):548-51. PubMed ID: 4073878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study.
    Ariza J; Gudiol F; Pallares R; Viladrich PF; Rufi G; Corredoira J; Miravitlles MR
    Ann Intern Med; 1992 Jul; 117(1):25-30. PubMed ID: 1596044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological, clinical, biochemical, and treatment characteristics of brucellosis cases in Turkey.
    Arslan M; Ertunç B; Düz ME; Menekşe E; Avci BY; Avci E; Yilmaz G
    J Infect Dev Ctries; 2024 Jul; 18(7):1066-1073. PubMed ID: 39078792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brucellosis.
    Pappas G; Akritidis N; Bosilkovski M; Tsianos E
    N Engl J Med; 2005 Jun; 352(22):2325-36. PubMed ID: 15930423
    [No Abstract]   [Full Text] [Related]  

  • 16. Brucella canis endocarditis: case report.
    Ying W; Nguyen MQ; Jahre JA
    Clin Infect Dis; 1999 Dec; 29(6):1593-4. PubMed ID: 10585833
    [No Abstract]   [Full Text] [Related]  

  • 17. [Sensitivity of Brucella melitensis to various antibiotics, drug preparations and their combinations].
    Samarina IV; Taran IF; Proskurina VA; Liapustina LV
    Antibiot Khimioter; 1991 Apr; 36(4):22-3. PubMed ID: 1892428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brucella melitensis bacteremia in children: review of 62 cases.
    Almuneef M; Memish ZA; Al Shaalan M; Al Banyan E; Al-Alola S; Balkhy HH
    J Chemother; 2003 Feb; 15(1):76-80. PubMed ID: 12678419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brucella melitensis infection in total knee arthroplasty: a case report.
    Erdogan H; Cakmak G; Erdogan A; Arslan H
    Knee Surg Sports Traumatol Arthrosc; 2010 Jul; 18(7):908-10. PubMed ID: 20119673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual versus triple therapy for uncomplicated brucellosis: A retrospective cohort study.
    Al-Madfaa RO; Alalawi MA; Basudan LO; Alhejaili SF; Eljaaly K; Madani TA; Thabit AK
    J Infect Dev Ctries; 2020 Dec; 14(12):1380-1386. PubMed ID: 33378279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.